1248 Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
1248 Management's REGN Position: Q2 2026 in Review
1248 Management reduced its Regeneron Pharmaceuticals (REGN) stake by 53% in Q2 2026, selling an estimated $329K and leaving 430 shares worth $268K. The position accounts for 0.1% of the portfolio, ranked #76.
1248 Management first reported a position in REGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $705K in Q1 2026. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- 1248 Management held 430 shares of Regeneron Pharmaceuticals worth $268K as of Q2 2026.
- 1248 Management sold 483 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $329K.
- Regeneron Pharmaceuticals made up 0.1% of 1248 Management's portfolio in Q2 2026, its #76 holding.
- 1248 Management first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- 1248 Management's Regeneron Pharmaceuticals position peaked at $705K in Q1 2026.
- 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on 1248 Management's 13F filing for Q2 2026, filed 13 Aug 2026.